Gov. Ron DeSantis Issues Executive Order Designed to Lower Costs of Prescription Drugs

On Friday, Governor Ron DeSantis issued an Executive Order (22-164) focused on lowering the costs of prescription drugs for Floridians by promoting transparency. The order will ensure reforms are in place to hold Pharmacy Benefits Managers (PBMs) accountable when managing prescription drug benefits for insurance companies. PBMs are third-party administrators of prescription drug programs.

Gov. Ron DeSantis signed the executive order at a press conference at Cape Coral High School.

“This executive order is really probably the first time Florida as a state has taken action to ensure that we’re saving money for Floridians regarding the middlemen and what happens with the prescription drug programs,” DeSantis said. “I think it’s going to be very, very meaningful.”

“For far too long leaders have chosen the path of inaction, rather than action, and fallen victim to a pharmaceutical system driven by drug companies rather than consumers,” said Agency for Health Care Administration Secretary Simone Marstiller. “Fortunately, Governor DeSantis leads with principle, always putting Floridians first and today’s actions will further this commitment by providing insight into the FDA’s review process and all agency health care contracts through the end of the decade.”

Read More

DeSantis Seeks Approval of Importation of Canadian Prescription Drugs

Gov. Ron DeSantis (R) is asking the Biden administration to approve a plan that would allow for the importation of FDA-approved Canadian drugs to the Sunshine State, which would lower costs, according to the governor. 

“Today, Governor Ron DeSantis called on the Biden Administration and leadership at the U.S. Department of Health and Human Services (HHS) to approve Florida’s Section 804 Importation Proposal (SIP) for Florida’s Canadian Prescription Drug Importation Program,” a Friday press release said

Read More